The current P/E ratio for West Pharmaceutical Services stock as of Sep 28, 2023 is 54.47. This is calculated based on the TTM EPS of $6.96 and the stock price of $379.08 per share. The PE ratio has increased by 35% from its last 4 quarters average of 40.2.
The average historical PE ratio of West Pharmaceutical Services for the last ten years is 42.58. The current price-to-earnings ratio of 54.47 is 28% more than the historical average. Analyzing the last ten years, WST's PE ratio reached its highest point in the Sep 2020 quarter at 64.99, when the price was $274.9 and the EPS was $4.23. The lowest point was recorded in the Sep 2013 quarter, when it reached 25.88 with a price of $41.15 and an EPS of $1.59.
Maximum annual increase: 52.25% in 2015
Maximum annual decrease: -43.33% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2022 | 29.9 | -43.33% |
| 2021 | 52.76 | -12.85% |
| 2020 | 60.54 | 31.69% |
| 2019 | 45.97 | 31.31% |
| 2018 | 35.01 | -27.62% |
| 2017 | 48.37 | 11.76% |
| 2016 | 43.28 | -4.42% |
| 2015 | 45.28 | 52.25% |
| 2014 | 29.74 | -2.4% |
| 2013 | 30.47 | 32.48% |
The current PE ratio of WST is above its 3, 5 and 10-year averages.
WST's PE ratio is above its peer stocks JNJ and MDT. West Pharmaceutical Services's current PE ratio of 54.47 is more than the average of its peers, which is 34.23.
| Stock name | PE ratio | Market cap |
|---|---|---|
| TFX Teleflex Inc | 25.23 | $9.3B |
| MDT Medtronic plc | 28.85 | $104.41B |
| JNJ Johnson & Johnson | 31.24 | $405.13B |
| SYK Stryker Corp | 38.49 | $104.5B |
| BDX Becton Dickinson & Co | 46.58 | $75.14B |
| WST West Pharmaceutical Services Inc | 54.43 | $27.98B |
| ICUI Icu Medical Inc | N/A | $2.87B |
| BAX Baxter International Inc | N/A | $19.08B |
| PLL Piedmont Lithium Inc | N/A | $766.97M |
As of Sep 28, 2023, WST stock has a price to earnings ratio of 54.47.
Over the last 3 years, the average PE ratio for WST stock is 47.38.
Over the last 5 years, the average PE ratio for WST stock is 46.66.
Over the last ten years, the quarterly PE ratio reached its highest level at 64.99 in the Sep 2020 quarter.
The current PE ratio of WST is 28% higher than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Sep 28, 2023), West Pharmaceutical Services's share price is $379.08. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2023 is $6.96. Therefore, West Pharmaceutical Services's price to earnings ratio for today is 54.47. PE RATIO(54.47) = STOCK PRICE($379.08) / TTM EPS($6.96)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.